Manganese superoxide dismutase is reduced in the liver of male but not female humans and rodents with non-alcoholic fatty liver disease
- PMID: 24161595
- DOI: 10.1016/j.yexmp.2013.10.003
Manganese superoxide dismutase is reduced in the liver of male but not female humans and rodents with non-alcoholic fatty liver disease
Abstract
Non-alcoholic fatty liver disease (NAFLD) is among the most common liver diseases. Oxidative stress is one of the pathogenic mechanisms contributing to the progression of simple fatty liver to non-alcoholic steatohepatitis (NASH). Manganese superoxide dismutase (MnSOD) is a mitochondrial antioxidative enzyme and here its expression in rodent and human NAFLD has been analyzed. MnSOD is found reduced in the liver of male mice fed a high fat diet and male ob/ob mice. Female mice fed an atherogenic diet to induce NASH have MnSOD protein levels comparable to controls. In a cohort of 30 controls, 41 patients with fatty liver and 39 NASH patients, MnSOD mRNA is significantly lower in the steatotic and NASH liver. When analyzed in both genders separately reduction of MnSOD expression is only found in males. Here, MnSOD mRNA negatively correlates with steatosis grade but not with extent of fibrosis or inflammation. MnSOD is, however, not reduced in primary human hepatocytes (PHH) treated with palmitate or oleate to increase cellular triglycerides. Lipopolysaccharide, TNF, IL-6, TGFβ and leptin which are all raised in NAFLD do not affect MnSOD in PHH. Adiponectin which attenuates oxidative stress partly by increasing MnSOD in macrophages does not induce MnSOD in PHH. In summary, current data show that hepatic MnSOD is reduced in male but not female humans and rodents with NAFLD.
Keywords: Fatty liver; Gender; Hepatocyte; Superoxide dismutase.
© 2013.
Similar articles
-
Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.Gut. 2011 Oct;60(10):1394-402. doi: 10.1136/gut.2010.222844. Epub 2011 Jan 26. Gut. 2011. PMID: 21270117
-
Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5. Metabolism. 2013. PMID: 23928105
-
MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis.Exp Mol Pathol. 2011 Oct;91(2):603-7. doi: 10.1016/j.yexmp.2011.07.001. Epub 2011 Jul 21. Exp Mol Pathol. 2011. PMID: 21791204
-
Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.Am J Gastroenterol. 2003 Sep;98(9):2093-7. doi: 10.1111/j.1572-0241.2003.07670.x. Am J Gastroenterol. 2003. PMID: 14499793 Review.
-
Relevance of CYP2E1 to non-alcoholic fatty liver disease.Subcell Biochem. 2013;67:165-75. doi: 10.1007/978-94-007-5881-0_5. Subcell Biochem. 2013. PMID: 23400921 Review.
Cited by
-
Lipid abnormalities in alpha/beta2-syntrophin null mice are independent from ABCA1.Biochim Biophys Acta. 2015 May;1851(5):527-36. doi: 10.1016/j.bbalip.2015.01.012. Epub 2015 Jan 24. Biochim Biophys Acta. 2015. PMID: 25625330 Free PMC article.
-
Relationship of adiponectin to markers of oxidative stress in type 2 diabetic patients: influence of incipient diabetes-associated kidney disease.Int Urol Nephrol. 2015 Jul;47(7):1173-80. doi: 10.1007/s11255-015-1004-2. Epub 2015 May 14. Int Urol Nephrol. 2015. PMID: 25971352
-
Hepatocyte expressed chemerin-156 does not protect from experimental non-alcoholic steatohepatitis.Mol Cell Biochem. 2022 Aug;477(8):2059-2071. doi: 10.1007/s11010-022-04430-3. Epub 2022 Apr 21. Mol Cell Biochem. 2022. PMID: 35449483 Free PMC article.
-
Annexin A6 protein is downregulated in human hepatocellular carcinoma.Mol Cell Biochem. 2016 Jul;418(1-2):81-90. doi: 10.1007/s11010-016-2735-9. Epub 2016 Jun 23. Mol Cell Biochem. 2016. PMID: 27334756
-
Machine learning uncovers manganese as a key nutrient associated with reduced risk of steatotic liver disease.Liver Int. 2024 Oct;44(10):2807-2821. doi: 10.1111/liv.16055. Epub 2024 Jul 31. Liver Int. 2024. PMID: 39082383
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous